IBanga le-Pharmaceutical 209216-23-9 Entecavir Monohydrate yoNyango lwe-Hepatitis B engapheliyo

Inkcazelo emfutshane:

Ubunyulu:≧99%, emhlophe ukuya kumgubo omhlophe

Umgangatho Womgangatho:Endlwini okanye njengoko kufuneka

Isatifikethi:I-COA, i-MOA, i-MSDS, njl

Umthamo:50Kg/ngenyanga

Beka ubomi kwishelufa:iminyaka eyi-2

Isicelo:Iyeza elisetyenziselwa ukunyanga i-hepatitis B engapheliyo

Iqela eliluncedo:Iqela lokuthengisa impahla ngaphandle elinamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	Entecavir monohydrate
Izithethantonye	I-2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
Inombolo yeCAS.	209216-23-9
Imbonakalo	Umgubo omhlophe ukuya kumhlophe
Ifomula yeemolekyuli	C₁₂H₁₅N₅O₃.H₂O
Ubunzima beMolekyuli	295.30
Ukusetyenziswa	IBanga lezamayeza okanye injongo yoPhando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

I-Entecavir monohydrate Cas: 209216-23-9
Izinto	Umgangatho	Iziphumo
Imbonakalo	Umgubo omhlophe ukuya kumhlophe	Iyahambelana
Ukujikeleza kwamehlo	+24.0°—+28.0°(DMF:MeOH=1:1 c=1%)	+27.0 °
Ukuchongwa	A: Nge-IR, Ukuhambelana nomgangatho wokusebenza	Iyahambelana
Ukuchongwa	B: Nge-HPLC, gcina ixesha kufuneka lihambelane nomgangatho wokusebenza	Iyahambelana
Amanzi	5.8%—6.5%	6.1%
Isomer	Inye ≤0.1%	0.02%
Isomer	Iyonke ≤0.5%	0.02%
Izinto ezinxulumeneyo	Ukungcola okukodwa ≤0.1%	0.05%
Izinto ezinxulumeneyo	Ubumdaka bubonke ≤0.3%	0.07%
Intsalela ekutshisweni	≤0.1%	0.04%
Iintsimbi ezinzima	£ 10ppm	Iyahambelana
Izinyibilikisi ezishiyekileyo	Kufuneka ihambelane nomgangatho	Iyahambelana
Isivavanyi	≥99.8%	99.9%
Isiphelo:Ithobela imigangatho yangaphakathi.

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf